Specom Biochemical, a leading name in the biochemical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 2005, the company has established itself as a key player in the development and production of high-quality biochemical products, including enzymes, amino acids, and specialty chemicals. With a commitment to innovation, Specom Biochemical stands out for its advanced manufacturing processes and rigorous quality control, ensuring that its products meet the highest industry standards. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. Recognised for its dedication to research and development, Specom Biochemical continues to drive advancements in the biochemical sector, catering to diverse industries such as pharmaceuticals, agriculture, and food production.
How does Specom Biochemical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Specom Biochemical's score of 5 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Specom Biochemical, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Specom Biochemical may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the biochemical industry, companies are increasingly expected to adopt transparent climate strategies and set measurable targets to mitigate their environmental impact. Without specific emissions data or reduction commitments, Specom Biochemical's climate strategy remains unclear, highlighting a potential area for future development in sustainability practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Specom Biochemical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
